blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2939660

EP2939660 - MICROGRANULAR FORMULATION INCLUDING AGGLOMERATE UNITS COMPRISING DISCONTINUOUS PHASE AND CONTINUOUS PHASE [Right-click to bookmark this link]
Former [2015/45]MICROGRANULAR FORMULATION INCLUDING COAGULATION UNIT COMPRISING DISCONTINUOUS PHASE AND CONTINUOUS PHASE
[2024/18]
StatusNo opposition filed within time limit
Status updated on  04.07.2025
Database last updated on 11.04.2026
FormerThe patent has been granted
Status updated on  26.07.2024
FormerGrant of patent is intended
Status updated on  14.04.2024
FormerExamination is in progress
Status updated on  01.06.2018
Most recent event   Tooltip24.10.2025Lapse of the patent in a contracting state
New state(s): CH, IE		published on 26.11.2025  [2025/48]
Applicant(s)For all designated states
CorePharm Co., Ltd.
5F, Garosu Bldg., 103, Bokjeong-ro
Sujeong-gu, Seongnam-si, Gyeonggi-do / KR
For all designated states
CorePharmbio Co., Ltd.
5F, Garosu Bldg., 103, Bokjeong-ro
Sujeong-gu, Seongnam-si, Gyeonggi-do / KR
[2016/43]
Former [2015/45]For all designated states
FNG Research Co. Ltd.
1-503
784 Biha-dong
Heungdeok-gu
Cheongju-si
Chungcheongbuk-do 361-825 / KR
Inventor(s)01 / GOO, Young Sam
101-2001 Kumho Eoullim Apt.
3366 Bokdae-dong
Heungdeok-gu
Cheongju-si Chungcheongbuk-do 361-805 / KR
02 / KIM, Jeong Tae
107-1404 (Ahyeon-dong, Gongduk Xi Apartment)
16, Mapo-daero 24-gil, Mapo-gu
Seoul / KR
 [2016/44]
Former [2015/45]01 / GOO, Young Sam
101-2001 Kumho Eoullim Apt.
3366 Bokdae-dong
Heungdeok-gu
Cheongju-si Chungcheongbuk-do 361-805 / KR
02 / KIM, Jeong Tae
304-905 Olympic Seonsuchon Apt.
89 Oryun-dong
Songpa-gu
Seoul 138-220 / KR
Representative(s)Louis Pöhlau Lohrentz
Patentanwälte
Postfach 30 55
90014 Nürnberg / DE
[2015/45]
Application number, filing date13866522.927.12.2013
[2015/45]
WO2013KR12351
Priority number, dateKR2012015863031.12.2012         Original published format: KR 20120158630
[2015/45]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014104844
Date:03.07.2014
Language:KO
[2014/27]
Type: A1 Application with search report 
No.:EP2939660
Date:04.11.2015
Language:EN
[2015/45]
Type: B1 Patent specification 
No.:EP2939660
Date:28.08.2024
Language:EN
[2024/35]
Search report(s)International search report - published on:KR03.07.2014
(Supplementary) European search report - dispatched on:EP11.07.2016
ClassificationIPC:A61K9/16, A61K47/26, A61K31/047, A61K31/4045, A61K31/445, A61K31/519, A61K31/138, A61K31/4178, A61K31/53, A61K45/06
[2024/18]
CPC:
A61K9/0056 (EP,US); A61K9/14 (KR); A61K31/047 (EP,US);
A61K31/138 (EP,US); A61K31/4045 (EP,US); A61K31/4178 (EP,US);
A61K31/445 (EP,US); A61K31/519 (EP,US); A61K31/53 (EP,US);
A61K45/06 (EP,US); A61K47/30 (KR); A61K9/16 (KR);
A61K9/1623 (EP,US); A61K9/1682 (US) (-)
C-Set:
A61K31/047, A61K2300/00 (US,EP);
A61K31/138, A61K2300/00 (EP,US);
A61K31/4045, A61K2300/00 (EP,US);
A61K31/4178, A61K2300/00 (EP,US);
A61K31/445, A61K2300/00 (US,EP);
A61K31/519, A61K2300/00 (US,EP);
A61K31/53, A61K2300/00 (US,EP)
(-)
Former IPC [2015/45]A61K9/14, A61K9/16, A61K47/30
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/45]  
Extension statesBANot yet paid
MENot yet paid
TitleGerman:MIKROGRANULÄRE FORMULIERUNG MIT AGGLOMERATE MIT DISKONTINUIERLICHER PHASE UND KONTINUIERLICHER PHASE[2024/18]
English:MICROGRANULAR FORMULATION INCLUDING AGGLOMERATE UNITS COMPRISING DISCONTINUOUS PHASE AND CONTINUOUS PHASE[2024/18]
French:FORMULATION MICROGRANULAIRE COMPRENANT DES UNITÉS AGGLOMÉRÉES COMPRENANT UNE PHASE DISCONTINUE ET UNE PHASE CONTINUE[2024/18]
Former [2015/45]MIKROGRANULÄRE FORMULIERUNG MIT KOAGULATIONSEINHEIT MIT DISKONTINUIERLICHER PHASE UND KONTINUIERLICHER PHASE
Former [2015/45]MICROGRANULAR FORMULATION INCLUDING COAGULATION UNIT COMPRISING DISCONTINUOUS PHASE AND CONTINUOUS PHASE
Former [2015/45]FORMULATION MICROGRANULAIRE COMPRENANT UNE UNITÉ DE COAGULATION COMPRENANT UNE PHASE DISCONTINUE ET UNE PHASE CONTINUE
Entry into regional phase14.07.2015Translation filed 
14.07.2015National basic fee paid 
14.07.2015Search fee paid 
14.07.2015Designation fee(s) paid 
14.07.2015Examination fee paid 
Examination procedure14.07.2015Examination requested  [2015/45]
31.01.2017Amendment by applicant (claims and/or description)
04.06.2018Despatch of a communication from the examining division (Time limit: M06)
12.12.2018Reply to a communication from the examining division
22.01.2019Despatch of a communication from the examining division (Time limit: M06)
01.08.2019Reply to a communication from the examining division
30.03.2020Despatch of a communication from the examining division (Time limit: M04)
30.07.2020Reply to a communication from the examining division
07.02.2023Despatch of a communication from the examining division (Time limit: M04)
05.06.2023Reply to a communication from the examining division
10.11.2023Despatch of a communication from the examining division (Time limit: M05)
11.03.2024Reply to a communication from the examining division
15.04.2024Communication of intention to grant the patent
22.07.2024Fee for grant paid
22.07.2024Fee for publishing/printing paid
22.07.2024Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.06.2018
Opposition(s)30.05.2025No opposition filed within time limit [2025/32]
Fees paidRenewal fee
29.12.2015Renewal fee patent year 03
14.12.2016Renewal fee patent year 04
14.12.2017Renewal fee patent year 05
11.12.2018Renewal fee patent year 06
16.12.2019Renewal fee patent year 07
28.12.2020Renewal fee patent year 08
25.11.2021Renewal fee patent year 09
13.12.2022Renewal fee patent year 10
18.12.2023Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ28.08.2024
ES28.08.2024
HR28.08.2024
MC28.08.2024
PL28.08.2024
SK28.08.2024
SM28.08.2024
NO28.11.2024
RS28.11.2024
GR29.11.2024
GB27.12.2024
IE27.12.2024
IS28.12.2024
CH31.12.2024
[2025/48]
Former [2025/47]CZ28.08.2024
ES28.08.2024
HR28.08.2024
MC28.08.2024
PL28.08.2024
SK28.08.2024
SM28.08.2024
NO28.11.2024
RS28.11.2024
GR29.11.2024
GB27.12.2024
IS28.12.2024
Former [2025/33]CZ28.08.2024
ES28.08.2024
HR28.08.2024
MC28.08.2024
PL28.08.2024
SK28.08.2024
SM28.08.2024
NO28.11.2024
RS28.11.2024
GR29.11.2024
IS28.12.2024
Former [2025/23]CZ28.08.2024
ES28.08.2024
HR28.08.2024
PL28.08.2024
SK28.08.2024
SM28.08.2024
NO28.11.2024
RS28.11.2024
GR29.11.2024
IS28.12.2024
Former [2025/21]ES28.08.2024
HR28.08.2024
PL28.08.2024
SM28.08.2024
NO28.11.2024
RS28.11.2024
GR29.11.2024
IS28.12.2024
Former [2025/10]ES28.08.2024
HR28.08.2024
PL28.08.2024
NO28.11.2024
RS28.11.2024
GR29.11.2024
IS28.12.2024
Former [2025/09]PL28.08.2024
NO28.11.2024
GR29.11.2024
IS28.12.2024
Former [2025/08]PL28.08.2024
NO28.11.2024
GR29.11.2024
Documents cited:Search[X] US2002071865  (KAJIYAMA ATUSHI et al.) [X] 1-8 * example 2 *
 [X] US6287596  (MURAKAMI TOSHIO et al.) [X] 1-4,6,8 * example 13 *
 [X] US5837285  (NAKAMICHI KOUICHI et al.) [X] 1-4,6,8 * example 5 *
International search[X] KR20060129106  (ASTELLAS PHARMA INC et al.) [X]
 [A] US2012237602  (IKEDA YUKI et al.) [A]
 [A] JP2011063627  (KYOWA HAKKO KIRIN CO LTD et al.) [A]
 [A]   FU, Y. ET AL.: "Orally Fast Disintegrating Tablets: Developments, Technologies, Taste-Masking and Clinical Studies", CRITICAL REVIEWSTM IN THERAPEUTIC DRUG CARRIER SYSTEMS, vol. 21, no. 6, 2004, pages 433 - 475, XP002603381 [A]

DOI:   http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v21.i6.10
ExaminationJPH11116466
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.